Bristol (BMY) Stake Held by Jnba Financial Advisors; Princeton Portfolio Strategies Group Has Boosted Texas Instrs (TXN) Holding by $690,150; Share Price Declined

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Jnba Financial Advisors increased its stake in Bristol (BMY) by 348.83% based on its latest 2018Q3 regulatory filing with the SEC. Jnba Financial Advisors bought 10,123 shares as the company’s stock declined 13.60% with the market. The institutional investor held 13,025 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $809,000, up from 2,902 at the end of the previous reported quarter. Jnba Financial Advisors who had been investing in Bristol for a number of months, seems to be bullish on the $83.22 billion market cap company. The stock increased 2.55% or $1.27 during the last trading session, reaching $50.98. About 14.61 million shares traded or 3.91% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 14.97% since February 14, 2018 and is downtrending. It has underperformed by 14.97% the S&P500. Some Historical BMY News: 03/05/2018 – European Medicines Agency Validates Bristol-Myers Squibb’s Type II Variation Application for Opdivo Plus Yervoy Combination; 23/05/2018 – MERCK & CO INC – KEYTRUDA COMBINATION MET DUAL PRIMARY ENDPOINTS OF OVERALL SURVIVAL (OS) AND PROGRESSION-FREE SURVIVAL (PFS) IN STUDY; 13/04/2018 – BRISTOL-MYERS SQUIBB- IN TRIAL, TWO SECONDARY ENDPOINTS OF ORR, MEDIAN DURATION OF RESPONSE DEMONSTRATED DURABILITY WITH OPDIVO VS DOCETAXEL; 12/04/2018 – PFIZER INC PFE.N : CITIGROUP SAYS CO’S CEO MADE CLEAR CO HAS NO INTEREST IN BRISTOL-MYERS SQUIBB IN ABSENCE OF TRANSFORMATIONAL DATA OR DE-RATING; 26/04/2018 – Health Care Up After Bristol Earnings — Health Care Roundup; 26/04/2018 – Bristol-Myers 1Q EPS 91c; 14/03/2018 – Rhode Island DoA: Bristol Warren Regional School District Wed, 3/14/2018, 6:30 PM; 29/05/2018 – Exelixis Announces U.S. FDA Accepts Supplemental New Drug Application For CABOMETYX(R) (cabozantinib) In Previously Treated Advanced Hepatocellular Carcinoma; 29/05/2018 – Phase lll lMpower130 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped People With Metastatic Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to; 18/04/2018 – BRISTOL-MYERS SQUIBB – OPDIVO SUBMISSION BASED ON SAFETY AND EFFICACY DATA FROM SCLC COHORT OF PHASE 1/2 CHECKMATE -032 TRIAL

Princeton Portfolio Strategies Group Llc increased its stake in Texas Instrs Inc (TXN) by 18.57% based on its latest 2018Q3 regulatory filing with the SEC. Princeton Portfolio Strategies Group Llc bought 6,450 shares as the company’s stock declined 13.40% with the market. The institutional investor held 41,175 shares of the semiconductors company at the end of 2018Q3, valued at $4.42 million, up from 34,725 at the end of the previous reported quarter. Princeton Portfolio Strategies Group Llc who had been investing in Texas Instrs Inc for a number of months, seems to be bullish on the $101.27 billion market cap company. The stock increased 0.67% or $0.71 during the last trading session, reaching $107.15. About 5.97 million shares traded. Texas Instruments Incorporated (NASDAQ:TXN) has declined 4.07% since February 14, 2018 and is downtrending. It has underperformed by 4.07% the S&P500. Some Historical TXN News: 22/05/2018 – Texas Instruments launches “STEM Squad” to keep students’ math and science skills sharp over the summer; 26/03/2018 – Texas Instruments to webcast its annual meeting of stockholders; 23/04/2018 – Texas Instruments Recognises Camtek for Its 2017 Supplier Excellence Award; 30/05/2018 – From vehicles to the factory, Tl mmWave sensors create a smarter world; 17/05/2018 – Australian Gov: WIPO PUBLISHES PATENT OF TEXAS INSTRUMENTS JAPAN AND TEXAS INSTRUMENTS FOR “DIGITAL MODULATOR ENTROPY SOURCE”; 24/04/2018 – TEXAS INSTRUMENTS SEES 2Q REV. $3.78B TO $4.10B, EST. $3.90B; 14/05/2018 – Texas Instruments Presenting at JPMorgan Conference Tomorrow; 30/05/2018 – From vehicles to the factory, TI mmWave sensors create a smarter world; 21/05/2018 – Texas Instruments at Bank of America Conference Jun 5; 30/04/2018 – Texas Instruments Presenting at JPMorgan Conference May 15

More notable recent Texas Instruments Incorporated (NASDAQ:TXN) news were published by: Nasdaq.com which released: “Ex-Dividend Reminder: Tanger Factory Outlet Centers, Citizens Financial Group and Texas Instruments – Nasdaq” on January 28, 2019, also Nasdaq.com with their article: “How to Turn A 6.9% Yield into a 16% Annual Dividend – Nasdaq” published on January 23, 2019, Nasdaq.com published: “Can Analog Strength Aid Texas Instruments (TXN) Q4 Earnings? – Nasdaq” on January 18, 2019. More interesting news about Texas Instruments Incorporated (NASDAQ:TXN) were released by: Nasdaq.com and their article: “Notable ETF Outflow Detected – SMH, TSM, AVGO, TXN – Nasdaq” published on January 08, 2019 as well as Nasdaq.com‘s news article titled: “Airline Stocks & TXN Report Earnings, Jobless Claims Reach Historic Lows – Nasdaq” with publication date: January 24, 2019.

Princeton Portfolio Strategies Group Llc, which manages about $199.15 million and $384.77M US Long portfolio, decreased its stake in Johnson & Johnson (NYSE:JNJ) by 4,416 shares to 81,125 shares, valued at $11.21 million in 2018Q3, according to the filing. It also reduced its holding in United Parcel Service Inc (NYSE:UPS) by 4,722 shares in the quarter, leaving it with 6,593 shares, and cut its stake in Ishares Inc (IEMG).

Among 43 analysts covering Texas Instruments (NASDAQ:TXN), 21 have Buy rating, 2 Sell and 20 Hold. Therefore 49% are positive. Texas Instruments had 135 analyst reports since July 24, 2015 according to SRatingsIntel. Ascendiant Capital Markets maintained it with “Buy” rating and $60 target in Thursday, July 23 report. The rating was maintained by Cowen & Co with “Market Perform” on Thursday, October 27. The firm earned “Hold” rating on Tuesday, January 23 by Mizuho. The stock of Texas Instruments Incorporated (NASDAQ:TXN) has “Neutral” rating given on Wednesday, October 25 by Nomura. The stock has “Buy” rating by BMO Capital Markets on Wednesday, October 25. The stock of Texas Instruments Incorporated (NASDAQ:TXN) has “Outperform” rating given on Friday, October 2 by RBC Capital Markets. Bernstein maintained it with “Buy” rating and $125.0 target in Wednesday, January 24 report. The firm earned “Outperform” rating on Thursday, April 28 by RBC Capital Markets. The stock of Texas Instruments Incorporated (NASDAQ:TXN) earned “Buy” rating by RBC Capital Markets on Sunday, August 27. The rating was maintained by Bank of America on Wednesday, July 25 with “Buy”.

Investors sentiment increased to 1.19 in 2018 Q3. Its up 0.05, from 1.14 in 2018Q2. It is positive, as 44 investors sold TXN shares while 372 reduced holdings. 125 funds opened positions while 372 raised stakes. 782.89 million shares or 1.44% less from 794.31 million shares in 2018Q2 were reported. Acadian Asset Lc holds 0.01% or 14,408 shares. Moreover, Wade G W & Inc has 0.03% invested in Texas Instruments Incorporated (NASDAQ:TXN). Arizona-based Arizona State Retirement Systems has invested 0.29% in Texas Instruments Incorporated (NASDAQ:TXN). Gsa Capital Prtn Llp reported 23,063 shares. Moreover, First Manhattan has 0.03% invested in Texas Instruments Incorporated (NASDAQ:TXN) for 52,545 shares. Richard C Young Co Ltd owns 56,917 shares. Mackay Shields Limited Liability Corporation reported 232,764 shares. First Fincl Bank Trust has invested 0.14% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN). Moreover, Tarbox Family Office has 0.02% invested in Texas Instruments Incorporated (NASDAQ:TXN). Prudential Inc holds 0.24% or 1.50M shares. Stock Yards Commercial Bank holds 4,068 shares or 0.04% of its portfolio. American National Registered Inv Advisor has 1.15% invested in Texas Instruments Incorporated (NASDAQ:TXN). Sunbelt Secs invested in 0.24% or 4,088 shares. Mackenzie Fincl reported 654,136 shares or 0.17% of all its holdings. 22,862 are held by Hodges Cap Inc.

Since October 25, 2018, it had 1 buy, and 19 insider sales for $32.23 million activity. 6,953 shares were sold by TROCHU CYNTHIA HOFF, worth $702,392 on Thursday, January 31. Van Haren Julie sold $402,732 worth of stock. Whitaker Darla H sold $601,658 worth of stock. TEMPLETON RICHARD K sold $9.19M worth of Texas Instruments Incorporated (NASDAQ:TXN) on Thursday, January 31. On Thursday, January 31 the insider Flessner Kyle M sold $936,455. ANDERSKOUV NIELS sold $2.34 million worth of stock.

Among 25 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 8 have Buy rating, 1 Sell and 16 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 100 analyst reports since July 28, 2015 according to SRatingsIntel. Barclays Capital maintained it with “Equal-Weight” rating and $65 target in Friday, October 13 report. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Monday, July 10 by Cowen & Co. BMO Capital Markets maintained Bristol-Myers Squibb Company (NYSE:BMY) on Friday, July 28 with “Underperform” rating. Jefferies maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Wednesday, August 23. Jefferies has “Buy” rating and $66.0 target. The firm earned “Buy” rating on Monday, December 19 by Jefferies. JP Morgan maintained the stock with “Overweight” rating in Monday, October 8 report. BMO Capital Markets maintained it with “Market Perform” rating and $54 target in Tuesday, October 23 report. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by Citigroup on Friday, February 16. The stock has “Hold” rating by Jefferies on Tuesday, June 14. The rating was downgraded by Citigroup to “Neutral” on Monday, October 22.

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Seekingalpha.com which released: “Bristol-Myers and Vedanta Biosciences collaborates to evaluate OPDIVO and VE800 in patients with advanced or metastatic cancers – Seeking Alpha” on December 10, 2018, also Seekingalpha.com with their article: “Bristol-Myers Squibb to transfer $3.8B in U.S. pension liabilities – Seeking Alpha” published on December 03, 2018, Seekingalpha.com published: “Bristol-Myers Squibb may be takeover target after Celgene bid – Credit Suisse – Seeking Alpha” on January 08, 2019. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Fool.com and their article: “Exelixis Grabs 90% of First Place – Motley Fool” published on February 13, 2019 as well as Finance.Yahoo.com‘s news article titled: “Economic Calendar – Top 5 Things to Watch This Week – Yahoo News” with publication date: January 19, 2019.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart